Suchergebnisse - "Jew, Scott"

PubPharm (7)

1

Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective study

enthalten in: European journal of haematology | 2023

von Regidor, B. | Jew, S. | Goldwater, M. | +8

2

Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients

enthalten in: Targeted oncology | 2023

von Jew, S. | Bujarski, S. | Regidor, B. | +6

3

Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma

enthalten in: Cancer reports (Hoboken, N.J.) | 2023

von Stampfer, S. | Bujarski, S. | Goldwater, M. | +10

4

Efficacy of venetoclax plus anti-CD38 monoclonal antibody-containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody

enthalten in: European journal of haematology | 2023

von Regidor, B. | Siddiqi, D. | Beatty, B. | +6

5

Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma

enthalten in: Clinical infection in practice | 2023

von Goldwater, M. | Stampfer, S. | Sean Regidor, B. | +7

6

Loss of anti‐spike antibodies following mRNA vaccination for COVID‐19 among patients with multiple myeloma

enthalten in: Cancer Reports | 2023

von Stampfer, S. | Bujarski, S. | Goldwater, M. | +10

7

Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression—A single center retrospective study

enthalten in: European Journal of Haematology | 2023

von Regidor, B. | Jew, S. | Goldwater, M. | +8

1
[1]